| Name | Sacituzumab |
|---|
| Description | Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |